PODD Strangle Strategy
PODD (Insulet Corporation), in the Healthcare sector, (Medical - Devices industry), listed on NASDAQ.
Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.
PODD (Insulet Corporation) trades in the Healthcare sector, specifically Medical - Devices, with a market capitalization of approximately $10.31B, a trailing P/E of 34.40, a beta of 1.20 versus the broader market, a 52-week range of 145.585-354.88, average daily share volume of 1.2M, a public-listing history dating back to 2007, approximately 5K full-time employees. These structural characteristics shape how PODD stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.20 places PODD roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a strangle on PODD?
A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.
Current PODD snapshot
As of May 15, 2026, spot at $148.01, ATM IV 45.40%, IV rank 38.26%, expected move 13.02%. The strangle on PODD below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this strangle structure on PODD specifically: PODD IV at 45.40% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 13.02% (roughly $19.26 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated PODD expiries trade a higher absolute premium for lower per-day decay. Position sizing on PODD should anchor to the underlying notional of $148.01 per share and to the trader's directional view on PODD stock.
PODD strangle setup
The PODD strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With PODD near $148.01, the first option leg uses a $155.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed PODD chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 PODD shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $155.00 | $5.35 |
| Buy 1 | Put | $140.00 | $4.60 |
PODD strangle risk and reward
- Net Premium / Debit
- -$995.00
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- -$995.00
- Breakeven(s)
- $130.05, $164.95
- Risk / Reward Ratio
- Unbounded
Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.
PODD strangle payoff curve
Modeled P&L at expiration across a range of underlying prices for the strangle on PODD. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -100.0% | +$13,004.00 |
| $32.73 | -77.9% | +$9,731.53 |
| $65.46 | -55.8% | +$6,459.06 |
| $98.18 | -33.7% | +$3,186.58 |
| $130.91 | -11.6% | -$85.89 |
| $163.63 | +10.6% | -$131.64 |
| $196.36 | +32.7% | +$3,140.83 |
| $229.08 | +54.8% | +$6,413.31 |
| $261.81 | +76.9% | +$9,685.78 |
| $294.53 | +99.0% | +$12,958.25 |
When traders use strangle on PODD
Strangles on PODD are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the PODD chain.
PODD thesis for this strangle
The market-implied 1-standard-deviation range for PODD extends from approximately $128.75 on the downside to $167.27 on the upside. A PODD long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current PODD IV rank near 38.26% is mid-range against its 1-year distribution, so the IV signal is neutral; the strangle thesis on PODD should anchor more to the directional view and the expected-move geometry. As a Healthcare name, PODD options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to PODD-specific events.
PODD strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. PODD positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move PODD alongside the broader basket even when PODD-specific fundamentals are unchanged. Always rebuild the position from current PODD chain quotes before placing a trade.
Frequently asked questions
- What is a strangle on PODD?
- A strangle on PODD is the strangle strategy applied to PODD (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With PODD stock trading near $148.01, the strikes shown on this page are snapped to the nearest listed PODD chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are PODD strangle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the PODD strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 45.40%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$995.00 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a PODD strangle?
- The breakeven for the PODD strangle priced on this page is roughly $130.05 and $164.95 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current PODD market-implied 1-standard-deviation expected move is approximately 13.02%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a strangle on PODD?
- Strangles on PODD are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the PODD chain.
- How does current PODD implied volatility affect this strangle?
- PODD ATM IV is at 45.40% with IV rank near 38.26%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.